RVOT Anomaly clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Sorry, in progress, not accepting new patients
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony TPV.
Los Angeles, California and other locations
Our lead scientists for RVOT Anomaly research studies include Gregory S. Perens, MD.
Last updated: